[Federal Register Volume 81, Number 186 (Monday, September 26, 2016)]
[Notices]
[Pages 66029-66030]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-23053]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee on Immunization Practices

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting of the aforementioned 
committee.
    Time and Date:
8:00 a.m.-6:00 p.m., EDT, October 19, 2016
8:00 a.m.-3:30 p.m., EDT, October 20, 2016
    Place: CDC, Tom Harkin Global Communications Center, 1600 Clifton 
Road NE., Building 19, Kent ``Oz'' Nelson Auditorium, Atlanta, Georgia 
30329.
    Status: Open to the public, limited only by the space available. 
Time will be available for public comment. The public is welcome to 
submit written comments in advance of the meeting. Comments should be 
submitted in writing by email to the contact person listed below. The 
deadline for receipt is October 11, 2016. All written comments must 
contain the name, address, and organizational affiliation of the 
speaker, as well as the topic being addressed. Written comments should 
not exceed one single-spaced typed page in length and delivered in 3 
minutes or less. Please note that the public comment period may end 
before the time indicated, following the last call for comments. 
Members of the public who wish to provide public comments should plan 
to attend the public comment session at the start time listed. Written 
comments received in advance

[[Page 66030]]

of the meeting will be included in the official record of the meeting.
    The meeting will be webcast live via the World Wide Web; for 
instructions and more information on ACIP please visit the ACIP Web 
site: http://www.cdc.gov/vaccines/acip/index.html.
    Purpose: The committee is charged with advising the Director, CDC, 
on the appropriate use of immunizing agents. In addition, under 42 
U.S.C. Sec. 1396s, the committee is mandated to establish and 
periodically review and, as appropriate, revise the list of vaccines 
for administration to vaccine-eligible children through the Vaccines 
for Children (VFC) program, along with schedules regarding the 
appropriate periodicity, dosage, and contraindications applicable to 
the vaccines. Further, under provisions of the Affordable Care Act, at 
section 2713 of the Public Health Service Act, immunization 
recommendations of the ACIP that have been adopted by the Director of 
the Centers for Disease Control and Prevention and appear on the CDC 
immunization schedules must be covered by applicable health plans.
    Matters for Discussion: The agenda will include discussions on: 
Meningococcal vaccines; human papillomavirus vaccines; influenza; 
hepatitis vaccines; pertussis vaccines; Respiratory Syncytial Virus 
(RSV); child and adolescent immunization schedule; adult immunization 
schedule; herpes zoster vaccine; yellow fever vaccine; pneumococcal 
vaccine and vaccine supply. A recommendation vote is scheduled for 
Hepatitis B vaccine, pertussis vaccine, human papillomavirus vaccines, 
meningococcal vaccines, child and adolescent immunization schedule, and 
adult immunization schedule. A Vaccines for Children (VFC) vote is 
scheduled for human papillomavirus vaccines, Hepatitis B vaccine and 
meningococcal vaccines. Agenda items are subject to change as 
priorities dictate.
    Contact Person for More Information: Stephanie Thomas, National 
Center for Immunization and Respiratory Diseases, CDC, 1600 Clifton 
Road NE., MS-A27, Atlanta, Georgia 30329, Telephone: (404) 639-8836; 
Email: [email protected].
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities for 
both the Centers for Disease Control and Prevention and the Agency for 
Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2016-23053 Filed 9-23-16; 8:45 am]
 BILLING CODE 4160-18-P